Current Pharmaceutical Design
Title: Editorial [Hot Topic: Bringing Drugs Into the Injured Brain and Keeping Them There (Executive Guest Editors: Dirk M. Hermann and Pauline Patak)]
Volume: 17 Issue: 26
Author(s): Dirk M. Hermann and Pauline Patak
Affiliation:
Keywords: Blood-brain barrier, multidrug resistance, neuroprotection failure
Export Options
About this article
Cite this article as:
M. Hermann Dirk and Patak Pauline, Editorial [Hot Topic: Bringing Drugs Into the Injured Brain and Keeping Them There (Executive Guest Editors: Dirk M. Hermann and Pauline Patak)], Current Pharmaceutical Design 2011; 17 (26) . https://dx.doi.org/10.2174/138161211797440177
DOI https://dx.doi.org/10.2174/138161211797440177 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacological Treatments for Fragile X Syndrome Based on Synaptic Dysfunction
Current Pharmaceutical Design Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?
Current Molecular Pharmacology The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Repetitive Transcranial Magnetic Stimulation for ALS
CNS & Neurological Disorders - Drug Targets The Therapeutic Potential of Melatonin in Neurological Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Current Gene Therapy Supercritical Extraction of Heracleum persicum Plant and Mathematical Modeling
The Natural Products Journal Progress and Outlooks in a Genetic Absence Epilepsy Model (WAG/Rij)
Current Medicinal Chemistry Strategies of Functional Foods Promote Sleep in Human Being
Current Signal Transduction Therapy A Retrospective, Multi-Center Cohort Study Evaluating the Severity- Related Effects of Cerebrolysin Treatment on Clinical Outcomes in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Activation of Kir2.3 Channels by Tenidap Suppresses Epileptiform Burst Discharges in Cultured Hippocampal Neurons
CNS & Neurological Disorders - Drug Targets Disorder in Milk Proteins: α-Lactalbumin. Part B. A Multifunctional Whey Protein Acting as an Oligomeric Molten Globular “Oil Container” in the Anti-Tumorigenic Drugs, Liprotides
Current Protein & Peptide Science Medical Applications of Implantable Drug Delivery Microdevices Based on MEMS (Micro-Electro-Mechanical-Systems)
Current Pharmaceutical Biotechnology Focusing on the Interactions between the GABAergic System and Neurosteroids in Neurodevelopmental Disorders
Current Pharmaceutical Design Transient Focal Lesions in the Splenium of the Corpus Callosum with Restricted Diffusion: An Enigma
Current Medical Imaging Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders CSF as a Surrogate for Assessing CNS Exposure: An Industrial Perspective
Current Drug Metabolism